Cargando…
Tripeptide tyroserleutide plus doxorubicin: therapeutic synergy and side effect attenuation
BACKGROUND: Tripeptide tyroserleutide (YSL) is a novel small molecule anti-tumor polypeptide that has been shown to inhibit the growth of human liver cancer cells. In this study, we investigated the effects of YSL plus doxorubicin on the growth of human hepatocellular carcinoma BEL-7402 cells that h...
Autores principales: | Zhu, Zhi-feng, Chen, Li-juan, Lu, Rong, Jia, Jing, Liang, Yu, Xu, Qiong, Zhou, Chun-lei, Wang, Li, Wang, Song, Yao, Zhi |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2601048/ https://www.ncbi.nlm.nih.gov/pubmed/19025669 http://dx.doi.org/10.1186/1471-2407-8-342 |
Ejemplares similares
-
Therapeutic effects of tyroserleutide on lung metastasis of human hepatocellular carcinoma SK-HEP-1 and its mechanism affecting ICAM-1 and MMP-2 and -9
por: Che, Xuchun, et al.
Publicado: (2018) -
Effective Antitumor of Orally Intestinal Targeting Penetrating Peptide-Loaded Tyroserleutide/PLGA Nanoparticles in Hepatocellular Carcinoma
por: Ma, Chenjun, et al.
Publicado: (2021) -
QSAR Study on Antioxidant Tripeptides and the Antioxidant Activity of the Designed Tripeptides in Free Radical Systems
por: Chen, Nan, et al.
Publicado: (2018) -
Therapeutic Effects of Tyroserleutide on Lung Metastasis of Human Hepatocellular Carcinoma SK-HEP-1 and Its Mechanism Affecting ICAM-1 and MMP-2 and -9 [Retraction]
Publicado: (2023) -
Tripeptide Leu-Pro-Phe from Corn Protein Hydrolysates Attenuates Hyperglycemia-Induced Neural Tube Defect in Chicken Embryos
por: Yan, Chang-Yu, et al.
Publicado: (2022)